BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27559122)

  • 1. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.
    Buchacz K; Lau B; Jing Y; Bosch R; Abraham AG; Gill MJ; Silverberg MJ; Goedert JJ; Sterling TR; Althoff KN; Martin JN; Burkholder G; Gandhi N; Samji H; Patel P; Rachlis A; Thorne JE; Napravnik S; Henry K; Mayor A; Gebo K; Gange SJ; Moore RD; Brooks JT;
    J Infect Dis; 2016 Sep; 214(6):862-72. PubMed ID: 27559122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
    Dankner WM; Lindsey JC; Levin MJ;
    Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Ylitalo N; Brogly S; Hughes MD; Nachman S; Dankner W; Van Dyke R; Seage GR;
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):778-87. PubMed ID: 16894075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.
    Kaplan JE; Hanson D; Dworkin MS; Frederick T; Bertolli J; Lindegren ML; Holmberg S; Jones JL
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S5-14. PubMed ID: 10770911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunistic Illnesses in Children With HIV Infection in the United States, 1997-2016.
    Nesheim SR; Balaji A; Hu X; Lampe M; Dominguez KL
    Pediatr Infect Dis J; 2021 Jul; 40(7):645-648. PubMed ID: 34014622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States.
    Gebo KA; Fleishman JA; Reilly ED; Moore RD;
    Med Care; 2005 Sep; 43(9 Suppl):III23-30. PubMed ID: 16116306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis.
    Detels R; Tarwater P; Phair JP; Margolick J; Riddler SA; Muñoz A;
    AIDS; 2001 Feb; 15(3):347-55. PubMed ID: 11273215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China.
    Xiao J; Gao G; Li Y; Zhang W; Tian Y; Huang Y; Su W; Han N; Yang D; Zhao H
    PLoS One; 2013; 8(10):e75915. PubMed ID: 24204583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.
    Melkamu MW; Gebeyehu MT; Afenigus AD; Hibstie YT; Temesgen B; Petrucka P; Alebel A
    BMC Infect Dis; 2020 Jan; 20(1):50. PubMed ID: 31948393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
    Moore RD; Chaisson RE
    Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database.
    Prasitsuebsai W; Kariminia A; Puthanakit T; Lumbiganon P; Hansudewechakul R; Siew Moy F; Law M; Kumarasamy N; Razali K; Sirisanthana V; Sohn AH; Chokephaibulkit K
    Pediatr Infect Dis J; 2014 Jul; 33(7):747-52. PubMed ID: 24378942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Low A; Gavriilidis G; Larke N; B-Lajoie MR; Drouin O; Stover J; Muhe L; Easterbrook P
    Clin Infect Dis; 2016 Jun; 62(12):1595-1603. PubMed ID: 26951573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.
    Coelho LE; Cardoso SW; Amancio RT; Moreira RI; Ribeiro SR; Coelho AB; Campos DP; Veloso VG; Grinsztejn B; Luz PM
    BMC Infect Dis; 2016 Mar; 16():134. PubMed ID: 27001753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment.
    Holmes CB; Wood R; Badri M; Zilber S; Wang B; Maartens G; Zheng H; Lu Z; Freedberg KA; Losina E
    J Acquir Immune Defic Syndr; 2006 Aug; 42(4):464-9. PubMed ID: 16810113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of opportunistic infections in adolescents and adults after the initiation of antiretroviral therapy: A 10-year retrospective cohort study in Ethiopia.
    Woldegeorgis BZ; Diro CW; Yohannes B; Kerbo AA; Asgedom YS
    Front Public Health; 2022; 10():1064859. PubMed ID: 36589962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts.
    Yazdanpanah Y; Chêne G; Losina E; Goldie SJ; Merchadou LD; Alfandari S; Seage GR; Sullivan L; Marimoutou C; Paltiel AD; Salamon R; Mouton Y; Freedberg KA
    Int J Epidemiol; 2001 Aug; 30(4):864-71. PubMed ID: 11511618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy.
    Sun HY; Chen MY; Hsieh SM; Sheng WH; Chang SY; Hsiao CF; Hung CC; Chang SC
    Jpn J Infect Dis; 2006 Oct; 59(5):311-6. PubMed ID: 17060697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India.
    Sharma SK; Kadhiravan T; Banga A; Goyal T; Bhatia I; Saha PK
    BMC Infect Dis; 2004 Nov; 4():52. PubMed ID: 15555069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.